Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441266 · ClinicalTrials.gov registry record · NA
M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis
A NA study of Radiation Dermatitis, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06441266 is a NA study of Radiation Dermatitis that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 16 participants, below the 47-participant average among 5 other Radiation Dermatitis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06441266, a NA study of Radiation Dermatitis, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation therapy.
Conditions Studied
Interventions
- DRUG KeraStat cream
- DEVICE M-PART Assessments via MyCap
- OTHER Clinical Assessments
- OTHER Feedback phone interview
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06441266
The ClinicalTrials.gov registry entry for NCT06441266 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47-participant average among 5 other Radiation Dermatitis trials with a reported enrollment target (66% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation Dermatitis appearing as the primary indexed condition, and to 4 interventions - of which KeraStat cream is the first listed.
NCT06441266 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06441266 about?
NCT06441266 is a clinical study titled "M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis". The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation therapy.
What is the current status of trial NCT06441266?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-05-08. Estimated completion is 2027-08.
What conditions does trial NCT06441266 study?
This clinical trial studies the following conditions: Radiation Dermatitis.
What interventions are being tested in trial NCT06441266?
The interventions under investigation include: KeraStat cream (DRUG), M-PART Assessments via MyCap (DEVICE), Clinical Assessments (OTHER), Feedback phone interview (OTHER).
Who is sponsoring clinical trial NCT06441266?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06441266 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
RECRUITING · NA
-
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
COMPLETED · NA
-
3M Cavilon Advanced Skin Protectant for the Prophylaxis of Radiation Dermatitis
COMPLETED
-
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
COMPLETED · Phase 3
-
Bacterial Decolonization to Prevent Radiation Dermatitis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.